Twinbeech Capital LP Bristol Myers Squibb CO Transaction History

Twinbeech Capital LP

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$40.25 - $52.99 $6.72 Million - $8.84 Million	166,840 New	166,840 $6.93 Million
Q3 2023 Nov 14, 2023	BUY	$57.89 - $64.73 $30.8 Million - $34.4 Million	531,873 New	531,873 $30.9 Million
Q1 2023 May 15, 2023	SELL	$65.71 - $74.53 $15.2 Million - $17.3 Million	-231,756 Reduced 90.47%	24,421 $1.69 Million
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $16 Million - $18.9 Million	233,221 Added 1015.95%	256,177 $18.4 Million
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $2,984 - $1.76 Million	22,956 New	22,956 $1.63 Million
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $7.32 Million - $8.53 Million	-136,448 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$59.17 - $69.31 $6.22 Million - $7.29 Million	105,169 Added 336.23%	136,448 $8.07 Million
Q2 2021 Aug 16, 2021	SELL	$61.91 - $67.42 $378,951 - $412,677	-6,121 Reduced 16.37%	31,279 $2.09 Million
Q1 2021 May 17, 2021	SELL	$59.34 - $66.74 $162,176 - $182,400	-2,733 Reduced 6.81%	37,400 $2.36 Million
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $2.32 Million - $2.63 Million	40,133 New	40,133 $2.49 Million
Q3 2020 Nov 16, 2020	SELL	$57.43 - $63.64 $4.24 Million - $4.69 Million	-73,772 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$54.82 - $64.09 $4.04 Million - $4.73 Million	73,772 New	73,772 $4.34 Million
Q1 2020 May 15, 2020	SELL	$46.4 - $67.43 $249,353 - $362,368	-5,374 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $264,454 - $344,957	5,374 New	5,374 $345,000

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $120B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Twinbeech Capital LP, based on Form 13F filings with the SEC.

Stay updated on Twinbeech Capital LP with notifications on news.